Filing Details

Accession Number:
0001209191-21-049724
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-04 17:39:17
Reporting Period:
2021-08-03
Accepted Time:
2021-08-04 17:39:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1699382 Pmv Pharmaceuticals Inc. PMVP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1666963 Winston Kung C/O Pmv Pharmaceuticals, Inc.
8 Clarke Drive, Suite 3
Cranbury NJ 08512
Coo, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-03 4,500 $3.22 6,100 No 4 M Direct
Common Stock Disposition 2021-08-03 4,500 $33.82 1,600 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-08-03 4,500 $0.00 4,500 $3.22
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
219,034 2028-02-21 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $3.22 2028-02-21 237,412 237,412 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2028-02-21 237,412 237,412 Indirect
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.75 to $34.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  3. The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant.
  4. All of the shares subject to the option are vested and immediately exercisable.
  5. The shares are held of record by the Winston Kung Irrevocable Family Trust for the benefit of the reporting person's immediate family.